Glucotrack, Inc. Enters Exchange Agreement for Promissory Note

On April 29, 2026, Glucotrack, Inc. entered into an Exchange Agreement with an investor to exchange an existing promissory note, originally for $3,600,000 and reduced to a lower amount, for a new promissory note of $988,000. This new note was then exchanged for 1,300,000 shares of the company's common stock. The exchange is subject to a beneficial ownership limitation, restricting the investor from holding more than 19.9% of the company's outstanding common stock. The issuance of shares is made under the exemption of Section 3(a)(9) of the Securities Act. The company also announced an updated investor presentation on April 30, 2026. This filing also incorporates information related to the creation of a direct financial obligation and unregistered sales of equity securities.